Hey looking for insight and maybe past experience in regards to remove super majority voting in a company. My understating of company operating with supermajority is that three quarter or commonly more of the shareholders need to vote the same way to approve something. NVAX is looking to remove supermajority and to go to majority voting which requires far less of agreement to approve something. Has anyone had any past experience with biotech company’s or any public business doing this. I read a lot about it and it makes sense that company’s will do this if they have someone trying to acquire them or are trying to make themselves acquirable since it will take much less shareholders agreeing to move forward with something. This company is currently undervalued with a p/s of 1.5 and a big pipeline of future drugs with the R&D done in my mind they make a good target for big pharma. let me know what you think and if you have seen company’s after releasing their products seek to lower the threshold for voting for potential takeover thanks!
Leave a Reply